Table 2.
Pre-treatment and post-treatment results within groups.
| Variables | One-to-one exercise group (n=16) | Group-based exercise group (n=26) | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Pre-treatment M±SD |
Post-treatment M±SD |
p* | Pre-treatment M±SD |
Post-treatment M±SD |
p* | |
| Fibromyalgia Impact Questionnaire | 55.04±18.48 | 32.80±22.19 | 0.001 | 62.44±17.80 | 46.39±22.26 | 0.000 |
| Health Assessment Questionnaire | 0.85±0.70 | 0.58±0.66 | 0.063 | 1.02±0.63 | 0.67±0.55 | 0.006 |
| Beck Anxiety Inventory | 21.12±12.85 | 16.75±13.41 | 0.108 | 26.57±12.54 | 20.88±10.09 | 0.004 |
| Short form-36 | ||||||
| Physical component | 145.83±67.39 | 196.50±95.37 | 0.003 | 138.07±74.46 | 196.82±81.94 | 0.000 |
| Mental component | 177.33±96.07 | 231.77±109.07 | 0.022 | 159.22±79.61 | 208.98±95.69 | 0.004 |
| Bilisşel Egzersiz Terapi Yaklaşı-mıbiopsychosocial questionnaire (0–120) | 35.60±20.03 | 25.62±17.67 | 0.038 | 41.88±19.64 | 31.53±19.90 | 0.001 |
*
Wilcoxon test.
M: mean; SD: standard deviation.